Cargando…
Expression of Bcl-2 in node-negative breast cancer is associated with various prognostic factors, but does not predict response to one course of perioperative chemotherapy.
The aim of this study was to assess relationships between Bcl-2 expression, response to chemotherapy and a number of pathological and biological tumour parameters in premenopausal, lymph node-negative breast cancer patients. Expression of Bcl-2 was determined using immunohistochemistry on paraffin-e...
Autores principales: | van Slooten, H. J., Clahsen, P. C., van Dierendonck, J. H., Duval, C., Pallud, C., Mandard, A. M., Delobelle-Deroide, A., van de Velde, C. J., van de Vijver, M. J. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1996
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2074622/ https://www.ncbi.nlm.nih.gov/pubmed/8679463 |
Ejemplares similares
-
Loss of Bcl-2 in invasive breast cancer is associated with high rates of cell death, but also with increased proliferative activity.
por: van Slooten, H. J., et al.
Publicado: (1998) -
Immunohistochemical detection of p53 and Bcl-2 in colorectal carcinoma: no evidence for prognostic significance.
por: Tollenaar, R. A., et al.
Publicado: (1998) -
Overexpression of P70 S6 kinase protein is associated with increased risk of locoregional recurrence in node-negative premenopausal early breast cancer patients
por: van der Hage, J A, et al.
Publicado: (2004) -
Outgrowth of BT-474 human breast cancer cells in immune-deficient mice: a new in vivo model for hormone-dependent breast cancer.
por: van Slooten, H. J., et al.
Publicado: (1995) -
A prolactin-dependent, metastasising rat mammary carcinoma as a model for endocrine-related tumour dormancy.
por: Wijsman, J. H., et al.
Publicado: (1991)